Last reviewed · How we verify

Calgel®

Ricerfarma S.r.l · Phase 3 active Small molecule

Calgel® is a topical oral gel formulation designed to provide local anesthetic and anti-inflammatory relief for oral pain and discomfort.

Calgel® is a topical oral gel formulation designed to provide local anesthetic and anti-inflammatory relief for oral pain and discomfort. Used for Oral pain relief (teething, mouth ulcers, oral irritation).

At a glance

Generic nameCalgel®
Also known asLidocaine 0.33% and Cetylpyridinium Chloride 0.10%
SponsorRicerfarma S.r.l
Drug classTopical oral analgesic/anesthetic
ModalitySmall molecule
Therapeutic areaDentistry/Oral Health
PhasePhase 3

Mechanism of action

Calgel® typically contains local anesthetic agents (such as benzocaine or lidocaine) combined with anti-inflammatory components to numb oral tissues and reduce inflammation. The formulation is applied directly to affected oral areas to provide symptomatic relief of pain associated with teething, mouth ulcers, or other oral conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results